Limited Partnership Agreement with SILP, with DME II as General Partner; the Company transferred rights to net investments to SILP in exchange for limited partnership interests.
Each officer opens the passage of the filing that names them. A title that changed since the list comes from the officer's latest Form 3, 4 or 5, and its start year is not stated there. "Not stated" means the filing does not say. Pay is the proxy's Summary Compensation Table, which reports only the named executive officers.
Rather than show a list that might be wrong, we show nothing. The board is in the proxy filed Apr 24, 2026.
Read the board in the proxyLimited Partnership Agreement with SILP, with DME II as General Partner; the Company transferred rights to net investments to SILP in exchange for limited partnership interests.
Performance allocation paid to DME II under the LPA.
Investment advisory agreement under which DME Advisors receives a management fee from SILP.
Letter Agreement limiting the Deployed GLRE Investment Portfolio to a percentage of GLRE Surplus and setting liquidation obligations for Excess Assets.
Company agreed to indemnify DME II and DME Advisors for claims arising from DME Advisors serving as SILP's investment advisor.
Service agreement under which DME Advisors provides investor relations services to the Company for monthly compensation.
Expenses incurred by the Company to DME Advisors for investor relations services.
Demand registration rights under the Shareholders' Agreement assigned to David Einhorn from Greenlight Capital Investors, LLC.
Collateral assets investment management agreement under which DME Advisors manages certain Company assets; DME Advisors receives no fees.
Loading...